TRIB News and Press, Trinity Biotech plc From 01/31/24

2024-01-31 07:28:19 ET More on Trinity Biotech Financial information for Trinity Biotech Read the full article on Seeking Alpha For further details see: Trinity Biotech reports Q3 results

DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) today announced the Company’s results for the quarter ended September 30, 2023. Business Updates and Strategic Priorities In December 2023, the Company announced the promotion of John Gillard ...

DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”) today announced that it has entered into a non-binding Letter of Intent with Bayer for the launch of a Continuous Glucose Monitoring (“CGM”) biosensor device in China ...

-Repositioning to a rapidly expanding biosensor market with potential for significant growth for the company as part of a revised strategy under our new management -Upfront payment of $12.5 million cash and 9 million ADSs -Strengthened investment relationship with Perceptive Advis...

DUBLIN, Ireland, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will host an investor call on Wednesday, January 31 at 8:30 AM E...

DUBLIN, Ireland, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announces it has begun commercial shipments to Kenya of its...

2023-12-18 16:39:51 ET More on Trinity Biotech Trinity Biotech plc (TRIB) Q2 2023 Earnings Call Transcript Financial information for Trinity Biotech For further details see: Trinity Biotech promotes finance chief John Gillard to CEO

John Gillard Named Chief Executive Officer Des Fitzgerald Named Interim Chief Financial Officer DUBLIN, Ireland, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the poin...

2023-11-28 16:14:20 ET More on Trinity Biotech Seeking Alpha’s Quant Rating on Trinity Biotech Historical earnings data for Trinity Biotech Financial information for Trinity Biotech For further details see: Trinity Biotech receives non-compliance n...

DUBLIN, Ireland, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that on November 21, 2023 the Company received n...